Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.

Manna, P R; Molehin, D; Ahmed, A U

Manna, P R; Molehin, D; Ahmed, A U.

Affiliation

Manna PR; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, United States. Electronic address: pulak.manna@ttuhsc.edu.
Molehin D; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, United States.
Ahmed AU; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, United States.

Prog Mol Biol Transl Sci ; 144: 487-537, 2016.

Article in En | MEDLINE | ID: mdl-27865465

Subject(s)

Aromatase/metabolism; Breast Neoplasms/enzymology; Endometrial Neoplasms/enzymology; Ovarian Neoplasms/enzymology; Estrogens/biosynthesis; Female; Histone Deacetylase Inhibitors/pharmacology; Humans; Receptors, Estrogen/metabolism

Key words

AIs; Aromatase; CYP19A1; Estrogens; HDACs; Targeted therapy; Tumors/cancers

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms / Aromatase / Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Prog Mol Biol Transl Sci Journal subject: BIOLOGIA MOLECULAR Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google